- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01693211
Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye Centre (1118)
This is a prospective, randomized study evaluating the circularity of the anterior capsulotomy performed by the VICTUS femtosecond work station (Group A) versus the manual capsulotomy (Group B) of a minimum of 22 eyes and maximum of 30 eyes per group diagnosed with cataract, scheduled to undergo removal by phacoemulsification with intraocular lens implantation in SNEC.
The primary study end point is to determine if the circularity of the created rhexis is better in Group A as compared to Group B.
The secondary study end point is to determine the diameter of rhexis is more precise and reproducible in Group A as compared to Group B.
Study Overview
Status
Conditions
Detailed Description
This clinical study is a controlled, open, randomized, prospective, single-centre, single-surgeon eye study to determine the precision of intraocular cuts for anterior capsulotomy in connection to cataract surgery and IOL implantation. The cuts are applied by means of the VICTUS femtosecond laser system using a cylindrical cut pattern with diameter and height dependent on anterior chamber depth, pupil diameter and ocular lens size for Group A and the manual surgery technique for Group B.
The allocation of the surgery technique will be randomized between the study patient. Each surgery technique represents a study group. In Group A the anterior capsulotomy and lens fragmentation will be performed by means of femtosecond laser surgery. Group B acts as a control group where the capsulotomy as well as the lens fragmentation is performed manually.
The hypothesis of the study is that by means of intraocular, laser-induced cuts, circularity of the capsulotomy can be improved in a safe and effective way.
A detailed pre-operative examination will ensure that every interested and willing patient fulfils the inclusion criteria of this study. Post-operative examinations, which should document the success of the treatment, are to be carried out after 1-day, 1-week, 1-month.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 168751
- Singapore National Eye Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Consenting patients undergoing phacoemulsification and IOL implant surgery for cataract, the diagnosis of which has been confirmed by another investigator.
- Clear cornea media
- Pupil must be able to dilate to at least 6mm in diameter measured with the pupil gauge
Exclusion Criteria:
- Pre-existing posterior capsule rupture Difference between maximum and minimum K-values must not be more than 5 D. The maximum K- value may not exceed 60 D and the minimal value may not be smaller than 37 D.
- Corneal disease or pathology that precludes transmission of laser wavelength or distortion of laser light.
- Subjects with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally.
- Lens/zonular instability such as, but not restricted to, Marfan's Syndrome, Pseudoexfoliation Syndrome, etc.
- Previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye.
- Patients with disorders of the ocular muscle, such as nystagmus or strabismus Keratoconus
- ACD < 1.8 mm or ACD > 4.5 mm
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
Capsulorhexis and pre-fragmentation of the nucleus are performed by the femtosecond laser.
|
Capsulotomy and pre-fragmentation of the nucleus are performed by the femtosecond laser.
|
|
Active Comparator: Group B
The Capulorhexis and nuclear fragmentation are performed manually.
|
Capsulorhexis and pre-fragmentation are performed manually.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Circularity of created rhexis
Time Frame: intraoperative
|
The primary study end point is to determine if the circularity of the created rhexis is better in Group A as compared to Group B. On the day of surgery immediately after the creation of the rhexis via an recorded surgical video.
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diameter of the created rhexis
Time Frame: intraoperative
|
The secondary study end point is to determine the diameter of rhexis is more precise and reproducible in Group A as compared to Group B. On the day of surgery immediately after the creation of the rhexis via an recorded surgical video.
|
intraoperative
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Centration of the created rhexis relative to the pupil
Time Frame: surgery day, 1-Day, 1-week, 1-Month
|
The additional outcome is to determine if the centration of the created rhexis relative to the pupil is better in Group A as compared to Group B. On the day of surgery immediately after the creation of the rhexis via an recorded surgical video and postoperative (1-Day, 1-week, 1-Month) based on slit lamp pictures.
|
surgery day, 1-Day, 1-week, 1-Month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Soon Phaik Chee, Assoc Prof, Singapore National Eye Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1118
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Disease: Cataract
-
University of California, San FranciscoSeva Foundation; Proctor FoundationNot yet recruitingCataract Surgery | Glasses | Eye Care | Primary Eye Care | Vision Center | Eyecare VisitsUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Siriraj HospitalCompletedSenile Cataract | Primary Angle Closure Glaucoma | Primary Angle Glaucoma Closure SuspectThailand
-
Military Institute of Medicine, PolandUnknownPrimary Open Angle Glaucoma, CataractPoland
-
Evidence Based Cataract Study GroupEye & ENT Hospital of Fudan UniversityRecruitingVisual Outcome | Congenital Cataract | Traumatic Cataract | Pediatric Cataract | Genetic AnticipationChina
-
Augusta UniversityRecruitingCataract; Eye DiseaseUnited States
-
Beaver-Visitec International, Inc.CompletedAphakia, Postcataract | Cataract; Eye DiseaseGermany, France, Spain
-
Military Institute od Medicine National Research...RecruitingCataract | Primary Open-Angle Glaucoma (POAG)Poland
-
Glaukos CorporationCompletedPrimary Open-angle GlaucomaUnited States
-
Vienna Institute for Research in Ocular SurgeryCompleted
Clinical Trials on Femtosecond Laser (VICTUS™ Femtosecond Laser Platform)
-
The Cleveland ClinicAlcon ResearchCompleted
-
Innovative MedicalCompleted
-
Innovative MedicalCompleted
-
Medical University of ViennaRecruiting
-
Durrie VisionAlcon ResearchCompletedMyopiaUnited States
-
Abbott Medical OpticsCompleted
-
Ospedale Santo StefanoIstituto di Fisica ApplicataCompletedCorneal Opacity | Keratoconus | Corneal DystrophiesItaly
-
Johnson & Johnson Surgical Vision, Inc.CompletedRefractive ErrorIndia, Singapore